E-DRUG: Editing/checking package inserts
----------------------------------------
Many Pharma companies insert their literature on the medicine for the
briefing of Medical profession
The claim of reputed companies on such leaflets is believable as they are
based on Scientific studies and findings at different stages/phases of Drug
discovery. [are you 100% sure? WB moderator]
But this may not always be true & applicable to some unscrupulus
companies who place their claim without much detail studies, more so in
respect of the side effects of their products /formulations. it is essential
that FDA of respective countries should have some mechanism to edit these
technical leaflets before they find their way in the market or to the
medical
profession lest it may lead to undesired side effects.
May i invite the comments of e-drug members in this direction?
Rooplal Shah
Pharma Consultant
India
rooplal@hotmail.com
[Anyone on the efficacy of drug regulatory authorities to edit/check the
package inserts? WB]
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug